What is the NOAEL for Ginsenoside Rd?
Ginsenoside Rd has 4 NOAEL studies in the database. The lowest reported value is WB232T95AV UNII. Source: openFDA substances.
NOAEL Data
Cosmetic Ingredient
Ginsenoside Rd
Also known as: β-D-Glucopyranoside, (3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-, (3β,12β)-20-(β-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside, 3-O-β-D-Glucopyranosyl-(1→2)-β-D-glucopyranosyl-20-O-β-D-glucopyranosyldammar-24-ene-3β,12β,20S-triol, 2-O-β-D-glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammara-24-en-3-yl-β-D-glucopyranoside, EC No.: 258-118-5 (+6 more)
CAS 52705-93-8
Ginsenoside Rd (CAS 52705-93-8) is a chemical substance. Key regulatory status: cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat.
SOURCE
noael studies public
NOAEL studies
4
SOURCE
chemical inventory jurisdictions
Regulatory lists
0
SOURCE
eu clp annex vi
GHS signal
Not classified
Chemical Identity
CAS, identifiers, formula, and alternate names for the matched substance record.
SOURCE
DSSTox identifiers
17 fields
Name
Ginsenoside Rd
CAS Number
52705-93-8
DTXSID
DTXSID301031221
Molecular Formula
C48H82O18
InChI Key
RLDVZILFNVRJTL-IWFVLDDISA-N
Monoisotopic Mass
946.550116
Synonyms
β-D-Glucopyranoside, (3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-(3β,12β)-20-(β-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside3-O-β-D-Glucopyranosyl-(1→2)-β-D-glucopyranosyl-20-O-β-D-glucopyranosyldammar-24-ene-3β,12β,20S-triol2-O-β-D-glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammara-24-en-3-yl-β-D-glucopyranosideEC No.: 258-118-5Chikusetsusaponin FK7Dammarane, β-D-glucopyranoside deriv.Ginsenoside Rd1Gypenoside VIII258-118-5EINECS 258-118-5
Functional Uses
Industrial and product-use categories associated with this substance.
SOURCE
EPA CPDat
1 records
Antioxidant
NOAEL Studies
Toxicology endpoints rendered from public NOAEL study rows.
SOURCE
NOAEL studies
Showing 4 of 4 studies
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| WB232T95AV | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| WB232T95AV | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| WB232T95AV | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| WB232T95AV | UNII | FDA UNII substance identifier | - | - | openFDA substances |
Showing 4 of 4 studies
Cosmetic Safety Profile
Same-CAS cosmetic ingredient record for cross-vertical context.
SOURCE
CosIng / Ingredients DB
EU Status
permitted
Max
-
Category
Antioxidant
Pharmaceutical Data
Same-CAS pharmaceutical records from drug and bioactivity sources.
SOURCE
EMBL-EBI ChEMBL
GINSENOSIDE RD
ChEMBL Phase
3
Adverse Events
0
Bioactivity
1
Cannabis Data
Same-CAS cannabis compliance and lab records where available.
SOURCE
Cannabis regulatory / lab data
efsa substances
1 cannabis record found in efsa substances.
View full cannabis profile →Frequently Asked Questions
Is Ginsenoside Rd used in cosmetics?
Yes, Ginsenoside Rd is also indexed as a cosmetic ingredient under the name Ginsenoside Rd. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Where does the safety data for Ginsenoside Rd come from?
Safety data is sourced from EPA ToxValDB, EPA CPDat, EPA DSSTox, CosIng / Ingredients DB, ChEMBL / DailyMed, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Is Ginsenoside Rd used outside industrial chemicals?
Ginsenoside Rd also appears in cosmetics, pharmaceutical, cannabis databases.